Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience

Elsevier, Annals of Oncology, 8(23), p. 1963-1967, 2012

Journal article published in 2012 by J. J. Wheler, A. M. Tsimberidou, D. S. Hong, A. Naing, G. S. Falchook, S. Fu

, S. Wen, R. Kurzrock

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by